Canada markets closed

Isracann Biosciences Inc. (ISCNF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0490-0.0015 (-2.97%)
At close: 02:03PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close0.0505
Open0.0480
BidN/A x N/A
AskN/A x N/A
Day's Range0.0480 - 0.0490
52 Week Range0.0250 - 0.2070
Volume10,200
Avg. Volume95,400
Market Cap7.158M
Beta (5Y Monthly)-0.35
PE Ratio (TTM)N/A
EPS (TTM)-0.1260
Earnings DateApr 27, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    Isracann Biosciences Subsidiary Praesidio Health Submits NPNs to Health Canada

    VANCOUVER, British Columbia, May 19, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) a multi-faceted organization with a natural health medicine division in Canada and holdings in Israel, is pleased to announce that its wholly owned subsidiary Praesidio Health has completed the natural product number (NPN) submissions to Health Canada for its first formulations. Praesidio Health (https://www.praesidiohealth.com/) is a Canadian medical re

  • GlobeNewswire

    Isracann Biosciences Renews Leadership to Meet Changing Demands

    VANCOUVER, British Columbia, April 15, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) is pleased to announce that further to its acquisition of Praesidio Health Inc. as a natural health medicine division, the Company has elected to expand its leadership team effective immediately. As Isracann moves from development to operations, and to better accommodate the integration of natural health medicine (“NHM”) research and development to mee

  • Baystreet

    Stocks in play: Isracann Biosciences Inc

    Announces that, further to the Company’s news releases dated February 23, 2022 and March 28, 2022, it ...